Fumonisin B2
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category | Enzyme inhibitors |
Catalog number | BBF-01855 |
CAS | 116355-84-1 |
Molecular Weight | 705.85 |
Molecular Formula | C34H59NO14 |
Purity | >95% |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
Fumonisin B2 is a liver toxin produced by Gibberella fujikuroi and Fumarium moniliforme. It is more cytotoxic than fumonisin B1. Fumonisin B2 inhibits sphingosine acyltransferase.
- Specification
- Properties
- Toxicity
- Reference Reading
- Spectrum
- Price Product List
Synonyms | 1,2,3-Propanetricarboxylic acid, 1,1'-(1-(12-amino-9,11-dihydroxy-2-methyltridecyl)-2-(1-methylpentyl)-1,2-ethanediyl) ester |
Storage | Store in a freezer upon arrival, at -10°C to -25°CUse the original container to store the product.Keep the lid tightly closed. |
IUPAC Name | (2R)-2-[2-[(5R,6R,7S,9S,16R,18S,19S)-19-amino-6-[(3R)-3,4-dicarboxybutanoyl]oxy-16,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid |
Canonical SMILES | CCCCC(C)C(C(CC(C)CCCCCCC(CC(C(C)N)O)O)OC(=O)CC(CC(=O)O)C(=O)O)OC(=O)CC(CC(=O)O)C(=O)O |
InChI | InChI=1S/C34H59NO14/c1-5-6-12-21(3)32(49-31(43)18-24(34(46)47)16-29(40)41)27(48-30(42)17-23(33(44)45)15-28(38)39)14-20(2)11-9-7-8-10-13-25(36)19-26(37)22(4)35/h20-27,32,36-37H,5-19,35H2,1-4H3,(H,38,39)(H,40,41)(H,44,45)(H,46,47)/t20-,21+,22-,23+,24+,25+,26-,27-,32+/m0/s1 |
InChI Key | UXDPXZQHTDAXOZ-STOIETHLSA-N |
Source | Fumonisin B2 is a fumonisin mycotoxin produced by the fungi Fusarium verticillioides and Fusarium moniliforme. Fumonisin B2 and other fumonisins frequently contaminate maize and other crops. |
Appearance | White to Pale Beige Solid |
Application | Carcinogens, Environmental |
Boiling Point | 705.92°C at 760 mmHg |
Melting Point | >79°C |
Density | 1.2044 g/cm3 |
Carcinogenicity | 2B, possibly carcinogenic to humans. |
Mechanism Of Toxicity | Fumonisins are similar in structure to the long-chain base backbones of sphingolipids, allowing it to inhibit of the biosynthesis of sphingosine and more complex sphingolipids by inhibiting the enzyme ceramide synthase. This causes the accumulation of sphinganine, sphingosine, and possibly also sphingosine 1-phosphate in cells and tissues, leading to apoptosis. |
LC-MS/MS Spectrum - 50V, Positive

Predicted LC-MS/MS Spectrum - 10V, Positive

Experimental Conditions
Collision Energy: 10 eV
Instrument Type: QTOF (generic), spectrum predicted by CFM-ID
Mass Resolution: 0.0001 Da
13C NMR Spectrum

Experimental Conditions
Nucleus: 13C
Frequency: 100
BBF-03963 | Pristinamycin | Inquiry |
BBF-00852 | Epothilon B | Inquiry |
BBF-00574 | Bestatin | Inquiry |
BBF-02576 | Pneumocandin B0 | Inquiry |
BBF-00569 | Aspoxicillin | Inquiry |
BBF-00664 | Alternariol | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
